Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

43
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
43
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

222
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
222
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

59
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
59
Microbial Growth Measurement: Direct Methods01:23

Microbial Growth Measurement: Direct Methods

Direct methods for measuring microbial populations in a culture are essential tools in microbiology, providing quantitative data for various applications. Among these, microscopic counts, plate counts, and serial dilution are widely used techniques, each with unique principles and applications.Microscopic CountsMicroscopic counting involves the use of a Petroff-Hausser chamber, a specialized microscope slide with a grid and defined depth. By observing a liquid culture under a microscope,...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

382
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
382
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

87
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
87

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Direct Electrical Stimulation of the Opercula.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society·2026
Same author

Real-Time Assessment of Factors Impacting Prognostic Predictions After Pediatric Cardiac Arrest: A Single-Center Prospective Study.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
Same author

Association of Parenting Stress in Early Childhood with Emotional Health and Resilience of Young Adults with Congenital Heart Disease.

The Journal of pediatrics·2026
Same author

Single-Eye NfL Measurement Using NULISA Technology Enables Reduction in Animal Use.

The AAPS journal·2026
Same author

Pediatric Emergency Department Care for Septic Shock in Sub-Saharan Africa: Single-Center Outcomes Before-Vs.-After Implementation of a Telesimulation Program, 2023-2024.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
Same author

Preparation of a polyclonal antibody against Lysosome-Associated Membrane Protein-1 for chicken and its application in the liver of broilers under chronic heat stress.

International journal of biological macromolecules·2026

相关实验视频

Updated: Jun 3, 2025

Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays
08:06

Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays

Published on: November 10, 2016

7.6K

使用单次稀释试验的药理动力学分析:提高精度,减少错误并增加吞吐量.

Saloumeh K Fischer1, Xiaome Xu2, Hayeun Ji2

  • 1Bioanalytical Sciences (BAS), Genentech Research and Early Development, South San Francisco, CA, USA.

Bioanalysis
|January 9, 2025
PubMed
概括

使用NUcleic acid链接免疫三明治测试 (NULISA) 技术的新型测试为蛋白质治疗量化提供了广泛的动态范围. 这简化了分析,减少了错误,并提高了临床试验的吞吐量.

关键词:
努利萨 (Nulisa) 是一个无关紧要的人.药物动力学 药物动力学自动化自动化自动化自动化动态范围的动态范围.乙醇化胺的使用方法

更多相关视频

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.8K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

相关实验视频

Last Updated: Jun 3, 2025

Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays
08:06

Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays

Published on: November 10, 2016

7.6K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.8K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

科学领域:

  • 生物化学 生化学
  • 分析化学 分析化学
  • 免疫技术是一种免疫技术.

背景情况:

  • 像ELISA,MSD和Gyrolab这样的既定方法用于临床试验中的蛋白质治疗量化.
  • 这些方法往往具有有限的动态范围,需要多次样本稀释.
  • 稀释步骤可以在试验结果中引入错误和变化.

研究的目的:

  • 开发和验证一种用于量化蛋白疗法的新型试验,其动态范围得到改善.
  • 与现有方法相比,评估新试验的性能.

主要方法:

  • 使用NUcleic acid链接免疫三明治测试 (NULISA) 平台开发药理动力学测试.
  • 评估试验的度动态范围及其对临床样本的表现.

主要成果:

  • NULISA平台使得能够开发一种药理动力学测定,其度动态范围超过6日志.
  • 所有临床样本可以通过单次稀释进行评估,简化了该过程.
  • 结果显示与ELISA和Gyrolab.com等已知方法有很好的相关性.

结论:

  • NULISA技术提供了高灵敏度,完全自动化,以及蛋白质定量化的广泛动态范围.
  • 这项技术简化了测试开发,简化了样本分析,最大限度地减少了错误,并增加了吞吐量.
  • 在临床环境中,NULISA代表了量化蛋白疗法的重大进步.